Maryland 2022 Regular Session

Maryland Senate Bill SB196

Introduced
1/12/22  
Refer
1/12/22  
Report Pass
2/14/22  
Engrossed
2/17/22  
Refer
2/22/22  
Report Pass
4/7/22  
Enrolled
4/11/22  
Chaptered
4/21/22  

Caption

Maryland Department of Health - Overdose Report

Impact

If enacted, SB196 will have a considerable impact on how the Maryland health authorities monitor and report on drug overdoses. The legislation not only continues the crucial examination of opioid-related fatalities but also incorporates data from various state and local agencies. The findings will inform the legislature and the public about the ongoing crisis of substance use disorder and opioid overdoses, fostering enhanced prevention strategies and the provision of services tailored to affected demographics.

Summary

Senate Bill 196 aims to extend the reporting requirements of the Maryland Department of Health regarding fatal overdoses involving opioids and other controlled substances. The bill mandates the Secretary of Health to examine the prescription and treatment histories of individuals who suffered fatal overdoses over the past four years and to provide annual reports outlining the findings. These reports are intended to highlight factors associated with overdose risks and assess state programs for opioid use and misuse, giving state authorities valuable data for prevention efforts.

Sentiment

Overall sentiment regarding SB196 appears to be supportive among healthcare advocates and lawmakers concerned about the opioid crisis. The move to enhance reporting is seen as a necessary step in addressing public health challenges. However, the bill has also raised questions regarding data collection methods and individual privacy concerns, which could lead to debates on how best to balance public health objectives with personal data rights.

Contention

One notable point of contention involves the potential implications of data sharing requirements outlined in the bill. While proponents argue that these efforts will lead to more effective substance use disorder interventions, there are concerns about the confidentiality of individual information and the extent to which agencies might access sensitive data. The legislation seeks to ensure that these identities are protected, yet some critics remain wary of the logistics involved in managing such data without compromising privacy.

Companion Bills

No companion bills found.

Similar Bills

MD HB950

Maryland Native Plants Program

MD SB836

Maryland Native Plants Program

MD HB161

Northeast Maryland Waste Disposal Authority - Evaluation, Termination of Bond Authority, and Assumption of Functions, Employees, and Contracts (Northeast Maryland Waste Disposal Authority Sunset Act)

MD HB1124

Maryland Department of Health - 2-1-1 Maryland, Maryland Think, and Maryland OneStop - Study

DE HCR156

Urging The State Of Maryland To Allow The Sale Of Certified Delaware Sod In Maryland.

MD SB14

Sustainable Maryland Program and Fund - Establishment

MD SB645

Maryland Trails Advisory Committee and the Maryland Office of Trails - Establishment (Great Maryland Trails Act)

MD HB530

Maryland Trails Advisory Committee and the Maryland Office of Trails - Establishment (Great Maryland Trails Act)